Novartis Pharma
9
63M
7
0.36
0.22
2
- Areas of investment
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.36
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (6)
- Health Care (5)
- Medical Device (3)
- Therapeutics (3)
- Pharmaceutical (3) Show 10 more
- Investments by region
-
- United States (7)
- Germany (1)
- Japan (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 107M
- Group Appearance index
- 0.89
- Avg. company exit year
- 22
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Alto Neuroscience | 25 Oct 2022 | Artificial Intelligence, Neuroscience, Biopharma | Early Stage Venture | 35M | United States, California, Los Altos |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.